The PI3K pathway in B cell metabolism

Critical Reviews in Biochemistry and Molecular Biology

Volumn 51, Issue 5, 2016, Pages 359-378

  Jellusova, Julia ^a,b   Rickert, Robert C ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c BURNHAM INSTITUTE   (United States)

Author keywords

Akt; glycolysis; lymphocyte; mitochondria; mTOR

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE;

AUTOPHAGY; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CANCER CELL; CELL MATURATION; CELL METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HEMATOLOGIC MALIGNANCY; HUMAN; INTRACELLULAR SIGNALING; METABOLIC ACTIVATION; METABOLIC STRESS; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; ANIMAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; METABOLISM; MITOCHONDRION; NEOPLASM; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIA; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84992418338     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.1080/10409238.2016.1215288     Document Type: Review

References (159)

1. M.Acharya, A.Sokolovska, J.M.Tam, et al. (2016). αv Integrins combine with LC3 and atg5 to regulate toll-like receptor signalling in B cells. Nat Commun 7:10917.
2. C.S.Ahn, C.M.Metallo (2015). Mitochondria as biosynthetic factories for cancer proliferation. Cancer Metab 3:1.
3. R.H.Amin, M.S.Schlissel (2008). Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol 9:613–22.
4. A.N.Anzelon, H.Wu, R.C.Rickert (2003). Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol 4:287–94.
5. P.Argyriou, P.Economopoulou, S.Papageorgiou (2012). The role of mTOR inhibitors for the treatment of B-cell lymphomas. Adv Hematol 2012:435342.
6. J.Arnold, D.Murera, F.Arbogast, et al. (2015). Autophagy is dispensable for B-cell development but essential for humoral autoimmune responses. Cell Death Differ 23:853–64.
7. G.V.Baracho, M.H.Cato, Z.Zhu, et al. (2014). PDK1 regulates B cell differentiation and homeostasis. Proc Natl Acad Sci USA 111:9573–8.
8. G.V.Baracho, A.V.Miletic, S.A.Omori, et al. (2011). Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation. Curr Opin Immunol 23:178–83.
9. S.Benhamron, B.Tirosh (2011). Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells. Eur J Immunol 41:2390–6.
10. M.Bertolotti, R.Sitia, A.Rubartelli (2012). On the redox control of B lymphocyte differentiation and function. Antioxid Redox Signal 16:1139–49.
11. A.P.Bhatt, S.R.Jacobs, A.J.Freemerman, et al. (2012). Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proc Natl Acad Sci U S A 109:11818–23.
12. P.M.Bhende, S.I.Park, M.S.Lim, et al. (2010) The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma. Leukemia 24:1781–4.
13. D.Blair, F.J.Dufort, T.C.Chiles (2012). Protein kinase Cbeta is critical for the metabolic switch to glycolysis following B-cell antigen receptor engagement. Biochem J 448:165–9.
14. G.J.Brunn, J.Williams, C.Sabers, et al. (1996). Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. Embo J 15:5256–67.
15. P.Bruno, A.Calastretti, M.Priulla, et al. (2007). Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles. Cell Signal 19:2118–26.
16. M.D.Buck, D.O'sullivan, E.L.Pearce (2015). T cell metabolism drives immunity. J Exp Med 212:1345–60.
17. M.Buzzai, D.E.Bauer, R.G.Jones, et al. (2005). The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 24:4165–73.
18. D.P.Calado, Y.Sasaki, S.A.Godinho, et al. (2012). The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers. Nat Immunol 13:1092–100.
19. M.Capasso, M.K.Bhamrah, T.Henley, et al. (2010). HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat Immunol 11:265–72.
20. P.Caro, A.U.Kishan, E.Norberg, et al. (2012). Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 22:547–60.
21. A.Caro-Maldonado, R.Wang, A.G.Nichols, et al. (2014). Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J Immunol 192:3626–36.
22. M.H.Cato, S.K.Chintalapati, I.W.Yau, et al. (2011). Cyclin D3 is selectively required for proliferative expansion of germinal center B cells. Mol Cell Biol 31:127–37.
23. M.Chen, M.J.Hong, H.Sun, et al. (2014). Essential role for autophagy in the maintenance of immunological memory against influenza infection. Nat Med 20:503–10.
24. M.Chen, S.Kodali, A.Jang, et al. (2015). Requirement for autophagy in the long-term persistence but not initial formation of memory B cells. J Immunol 194:2607–15.
25. C.Chen, Y.Liu, R.Liu, et al. (2008). TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 205:2397–408.
26. S.H.Cho, A.K.Ahn, P.Bhargava, et al. (2011). Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family. Proc Natl Acad Sci USA 108:15972–7.
27. I.Chopra, H.F.Li, H.Wang, K.A.Webster (2012). Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Diabetologia 55:783–94.
28. X.Ci, M.Kuraoka, H.wang, et al. (2015). TSC1 promotes B cell maturation but is dispensable for germinal center formation. PLoS One 10:e0127527.
29. E.Clayton, G.Bardi, S.E.Bell, et al. (2002). A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 196:753–63.
30. J.L.Coloff, E.F.Mason, B.J.Altman, et al. (2011). Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells. J Biol Chem 286:5921–33.
31. K.L.Conway, P.Kuballa, B.Khor, et al. (2013). ATG5 regulates plasma cell differentiation. Autophagy 9:528–37.
32. D.A.Cross, D.R.Alessi, P.Cohen, et al. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785–9.
33. P.Delgado, B.Cubelos, E.Calleja, et al. (2009). Essential function for the GTPase TC21 in homeostatic antigen receptor signaling. Nat Immunol 10:880–8.
34. H.S.Dengler, G.V.Baracho, S.A.Omori, et al. (2008). Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol 9:1388–98.
35. N.Dil, A.J.Marshall (2009). Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation. Mol Immunol 46:1970–8.
36. J.Ding, T.Takano, S.Gao, et al. (2000). Syk is required for the activation of Akt survival pathway in B cells exposed to oxidative stress. J Biol Chem 275:30873–7.
37. D.Dominguez-Sola, J.Kung, A.B.Holmes, et al. (2015). The FOXO1 transcription factor instructs the germinal center dark zone program. Immunity 43:1064–74.
38. D.Dominguez-Sola, G.D.Victora, C.Y.Ying, et al. (2012). The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nat Immunol 13:1083–91.
39. A.C.Donahue, D.A.Fruman (2003). Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation. J Immunol 170:5851–60.
40. C.A.Doughty, B.F.Bleiman, D.J.Wagner, et al. (2006). Antigen receptor-mediated changes in glucose metabolism in B lymphocytes:role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107:4458–65.
41. F.J.Dufort, B.F.Bleiman, M.R.Gumina, et al. (2007). Cutting edge:IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J Immunol 179:4953–7.
42. F.J.Dufort, M.R.Gumina, N.L.Ta, et al. (2014). Glucose-dependent de novo lipogenesis in B lymphocytes:a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. J Biol Chem 289:7011–24.
43. E.A.Dunlop, A.R.Tee (2014). mTOR and autophagy:a dynamic relationship governed by nutrients and energy. Semin Cell Dev Biol 36:121–9.
44. K.Duvel, J.L.Yecies, S.Menon, et al. (2010). Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39:171–83.
45. I.El-Najjar, T.Barwick, N.Avril, S.Montoto (2012). The role of FDG-PET and bone marrow examination in lymphoma staging. Ann Oncol 23:x89–91.
46. R.L.Elstrom, D.E.Bauer, M.Buzzai, et al. (2004). Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64:3892–9.
47. X.Fang, S.X.Yu, Y.Lu, et al. (2000). Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA 97:11960–5.
48. X.Fang, X.Zhou, X.Wang (2013). Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma. Biomark Res 1:30.
49. B.Faubert, G.Boily, S.Izreig, et al. (2013). AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab 17:113–24.
50. K.A.Frauwirth, J.L.Riley, M.H.Harris, et al. (2002). The CD28 signaling pathway regulates glucose metabolism. Immunity 16:769–77.
51. D.A.Fruman, C.Rommel (2011). PI3Kδ inhibitors in cancer:rationale and serendipity merge in the clinic. Cancer Discov 1:562–72.
52. D.A.Fruman, C.Rommel (2014). PI3K and cancer:lessons, challenges and opportunities. Nat Rev Drug Discov 13:140–56.
53. T.Fukuda, T.Yoshida, S.Okada, et al. (1997). Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med 186:439–48.
54. M.Gao, J.Liang, Y.Lu, et al. (2014). Site-specific activation of AKT protects cells from death induced by glucose deprivation. Oncogene 33:745–55.
55. J.M.Garcia-Manteiga, S.Mari, M.Godejohann, et al. (2011). Metabolomics of B to plasma cell differentiation. J Proteome Res 10:4165–76.
56. V.A.Gerriets, R.J.Kishton, A.G.Nichols, et al. (2015). Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J Clin Invest 125:194–207.
57. C.K.Goo, H.Y.Lim, Q.S.Ho, et al. (2012). PTEN/Akt signaling controls mitochondrial respiratory capacity through 4E-BP1. PLoS One 7:e45806.
58. A.K.Gopal, B.S.Kahl, S.De Vos, et al. (2014). PI3Kdelta inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med 370:1008–18.
59. K.Gottlob, N.Majewski, S.Kennedy, et al. (2001). Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15:1406–18.
60. D.R.Green, L.Galluzzi, G.Kroemer (2014). Cell biology. Metabolic control of cell death. Science 345:1250256.
61. M.A.Gregory, Y.QIY, S.R.Hann (2003). Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 278:51606–12.
62. R.J.Grumont, A.Strasser, S.Gerondakis (2002). B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-kappaB regulated c-myc transcription. Mol Cell 10:1283–94.
63. C.Gulmann, V.Espina, E.PetricoinIII, et al. (2005). Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin Cancer Res 11:5847–55.
64. D.M.Gwinn, D.B.Shackelford, D.F.Egan, et al. (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30:214–26.
65. S.Hartmann, C.Agostinelli, J.Diener, et al. (2012). GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers. BMC Cancer 12:586.
66. S.Hasselblom, U.Hansson, M.Olsson, et al. (2010). High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Br J Haematol 149:560–8.
67. S.E.Herman, A.L.Gordon, A.J.Wagner, et al. (2010). Phosphatidylinositol 3-kinase-delta inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals. Blood 116:2078–88.
68. J.Y.Hong, M.E.Hong, M.K.Choi, et al. (2014). The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma:a clinicopathological study of 262 cases. Ann Oncol 25:182–8.
69. T.Hoshii, Y.Tadokoro, K.Naka, et al. (2012). mTORC1 is essential for leukemia propagation but not stem cell self-renewal. J Clin Invest 122:2114–29.
70. S.A.Hudak, S.O.Gollnick, D.H.Conrad, M.R.Kehry (1987). Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells. Proc Natl Acad Sci USA 84:4606–10.
71. K.Inoki, Y.Li, T.Zhu, et al. (2002). TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4:648–57.
72. K.Inoki, H.Ouyang, T.Zhu, et al. (2006). TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126:955–68.
73. K.Inoki, T.Zhu, K.L.Guan (2003). TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577–90.
74. K.J.Jang, H.Mano, K.Aoki, et al. (2015). Mitochondrial function provides instructive signals for activation-induced B-cell fates. Nat Commun 6:6750.
75. J.Jellusova, A.V.Miletic, M.CATOMH, et al. (2013). Context-specific BAFF-R signaling by the NF-κB and PI3K pathways. Cell Rep 5:1022–35.
76. J.L.Jewell, K.L.Guan (2013). Nutrient signaling to mTOR and cell growth. Trends Biochem Sci 38:233–42.
77. S.T.Jou, N.Carpino, Y.Takahashi, et al. (2002). Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol 22:8580–91.
78. R.Keating, T.Hertz, M.Wehenkel, et al. (2013). The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus. Nat Immunol 14:1266–76.
79. Y.M.Kim, Y.H.Seo, C.B.Park, et al. (2010). Roles of GSK3 in metabolic shift toward abnormal anabolism in cell senescence. Ann N Y Acad Sci 1201:65–71.
80. Y.M.Kim, I.Song, Y.H.Seo, G.Yoon (2013). Glycogen synthase kinase 3 inactivation induces cell senescence through sterol regulatory element binding protein 1-mediated lipogenesis in Chang cells. Endocrinol Metab (Seoul) 28:297–308.
81. H.Kojima, A.Kobayashi, D.Sakurai, et al. (2010). Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine B cell development in bone marrow. J Immunol 184:154–63.
82. G.S.Krasnov, A.A.Dmitriev, V.A.Lakunina, et al. (2013). Targeting VDAC-bound hexokinase II:a promising approach for concomitant anti-cancer therapy. Expert Opin Ther Targets 17:1221–33.
83. M.Laplante, D.M.Sabatini (2012). mTOR signaling in growth control and disease. Cell 149:274–93.
84. A.S.Lazorchak, D.Liu, V.Facchinetti, et al. (2010). Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells. Mol Cell 39:433–43.
85. A.Le, A.N.Lane, M.Hamaker, et al. (2012). Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 15:110–21.
86. K.Lee, L.Heffington, J.Jellusova, et al. (2013). Requirement for Rictor in homeostasis and function of mature B lymphoid cells. Blood 122:2369–79.
87. Y.Li, L.He, N.Zeng, et al. (2013). Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) signaling regulates mitochondrial biogenesis and respiration via estrogen-related receptor alpha (ERRalpha). J Biol Chem 288:25007–24.
88. R.Lill, B.Hoffmann, S.Molik, et al. (2012). The role of mitochondria in cellular iron-sulfur protein biogenesis and iron metabolism. Biochim Biophys Acta 1823:1491–508.
89. J.J.Limon, D.A.Fruman (2012). Akt and mTOR in B cell activation and differentiation. Front Immunol 3:228.
90. J.J.Limon, L.So, S.Jellbauer, et al. (2014). mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition. Proc Natl Acad Sci USA 111:E5076–85.
91. T.Liu, R.J.Kishton, A.N.Macintyre, et al. (2014). Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis. Cell Death Dis 5:e1470.
92. K.Macaulay, A.S.Blair, E.Hajduch, et al. (2005). Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells. J Biol Chem 280:9509–18.
93. A.Majchrzak, M.Witkowska, P.Smolewski (2014). Inhibition of the PI3K/Akt/mTOR signaling pathway in diffuse large B-cell lymphoma:current knowledge and clinical significance. Molecules 19:14304–15.
94. A.Mayer, S.Denanglaire, B.Viollet, et al. (2008). AMP-activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function. Eur J Immunol 38:948–56.
95. S.K.Mcbrayer, J.C.Cheng, S.Singhal, et al. (2012). Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11:implications for glucose transporter-directed therapy. Blood 119:4686–97.
96. N.P.Mena, P.J.Urrutia, F.Lourido, et al. (2015). Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders. Mitochondrion 21:92–105.
97. R.D.Michalek, V.A.Gerriets, S.R.Jacobs, et al. (2011a). Cutting edge:distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol 186:3299–303.
98. R.D.Michalek, V.A.Gerriets, A.G.Nichols, et al. (2011b). Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation. Proc Natl Acad Sci USA 108:18348–53.
99. B.C.Miller, Z.Zhao, L.M.Stephenson, et al. (2008). The autophagy gene ATG5 plays an essential role in B lymphocyte development. Autophagy 4:309–14.
100. H.Morbach, J.N.Schickel, C.Cunningham-Rundles, et al. (2015). CD19 controls Toll-like receptor 9 responses in human B cells. J Allergy Clin Immunol 137:889–98.
101. Y.Nishida, S.Arakawa, K.Fujitani, et al. (2009). Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461:654–8.
102. V.Nogueira, Y.Park, C.C.Chen, et al. (2008). Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14:458–70.
103. C.J.Norbury, B.Zhivotovsky (2004). DNA damage-induced apoptosis. Oncogene 23:2797–808.
104. K.J.Oestreich, K.A.Read, S.E.Gilbertson, et al. (2014). Bcl-6 directly represses the gene program of the glycolysis pathway. Nat Immunol 15:957–64.
105. W.J.Oh, E.Jacinto (2011). mTOR complex 2 signaling and functions. Cell Cycle 10:2305–16.
106. T.Okada, A.Maeda, A.Iwamatsu, et al. (2000). BCAP:the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 13:817–27.
107. S.A.Omori, M.H.Cato, A.Anzelon-Mills, et al. (2006). Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. Immunity 25:545–57.
108. D.C.Otero, S.A.Omori, R.C.Rickert (2001). Cd19-dependent activation of Akt kinase in B-lymphocytes. J Biol Chem 276:1474–8.
109. K.L.Otipoby, Y.Sasaki, M.Schmidt-Supprian, et al. (2008). BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc Natl Acad Sci USA 105:12435–8.
110. I.Papandreou, T.Goliasova, N.C.Denko (2011). Anticancer drugs that target metabolism:is dichloroacetate the new paradigm? Int J Cancer 128:1001–8.
111. H.Park, K.Staehling, M.Tsang, et al. (2012). Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development. Immunity 36:769–81.
112. A.Patke, I.Mecklenbrauker, H.Erdjument-Bromage, et al. (2006). BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 203:2551–62.
113. H.C.Patterson, C.Gerbeth, P.Thiru, et al. (2015). A respiratory chain controlled signal transduction cascade in the mitochondrial intermembrane space mediates hydrogen peroxide signaling. Proc Natl Acad Sci USA 112:E5679–88.
114. S.D.Pauls, S.T.Lafarge, I.Landego, et al. (2012). The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells:activation mechanisms, regulation and impact on cellular functions. Front Immunol 3:224.
115. E.L.Pearce, M.C.Walsh, P.J.Cejas, et al. (2009). Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460:103–7.
116. N.Pengo, M.Scolari, L.Oliva, et al. (2013). Plasma cells require autophagy for sustainable immunoglobulin production. Nat Immunol 14:298–305.
117. M.Pfeifer, M.Grau, D.Lenze, et al. (2013). PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 110:12420–5.
118. S.Qin, P.B.Chock (2003). Implication of phosphatidylinositol 3-kinase membrane recruitment in hydrogen peroxide-induced activation of PI3K and Akt. Biochemistry 42:2995–3003.
119. F.Ramadani, D.J.Bolland, F.Garcon, et al. (2010). The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development. Sci Signal 3:ra60.
120. J.C.Rathmell, C.J.Fox, D.R.Plas, et al. (2003). Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 23:7315–28.
121. J.P.Ray, M.M.Staron, J.A.Shyer, et al. (2015). The interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T Helper 1 and follicular B helper T cells. Immunity 43:690–702.
122. K.Reif, K.Okkenhaug, T.Sasaki, et al. (2004). Cutting edge:differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol 173:2236–40.
123. M.Reth (2002). Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 3:1129–34.
124. S.M.Richards, E.A.Clark (2009). BCR-induced superoxide negatively regulates B-cell proliferation and T-cell-independent type 2 Ab responses. Eur J Immunol 39:3395–403.
125. R.C.Rickert (2013). New insights into pre-BCR and BCR signalling with relevance to B cell malignancies. Nat Rev Immunol 13:578–91.
126. R.C.Rickert, K.Rajewsky, J.Roes (1995). Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352–5.
127. D.J.Roberts, V.P.Tan-Sah, J.M.Smith, S.Miyamoto (2013). Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes. J Biol Chem 288:23798–806.
128. S.Sander, V.T.Chu, T.Yasuda, et al. (2015). PI3 kinase and FOXO1 transcription factor activity differentially control B cells in the germinal center light and dark zones. Immunity 43:1075–86.
129. D.K.Singh, D.Kumar, Z.Siddiqui, et al. (2005). The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal. Cell 121:281–93.
130. T.G.Sommermann, K.O'Neill, D.R.Plas, E.Cahir-McFarland (2011). IKKbeta and NF-kappaB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1. Cancer Res 71:7291–300.
131. L.Srinivasan, Y.Sasaki, D.P.Calado, et al. (2009). PI3 kinase signals BCR-dependent mature B cell survival. Cell 139:573–86.
132. M.Sukumar, J.Liu, Y.Ji, et al. (2013). Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J Clin Invest 123:4479–88.
133. M.Surjit, S.K.Lal (2007). Glycogen synthase kinase-3 phosphorylates and regulates the stability of p27kip1 protein. Cell Cycle 6:580–8.
134. C.Sutherland, I.A.Leighton, P.Cohen (1993). Inactivation of glycogen synthase kinase-3 beta by phosphorylation:new kinase connections in insulin and growth-factor signalling. Biochem J 296:15–9.
135. A.Suzuki, T.Kaisho, M.Ohishi, et al. (2003a). Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med 197:657–67.
136. A.Suzuki, G.Kusakai, A.Kishimoto, et al. (2003b). Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J Biol Chem 278:48–53.
137. N.Tejeda-Munoz, M.Robles-Flores (2015). Glycogen synthase kinase 3 in Wnt signaling pathway and cancer. IUBMB Life 67:914–22.
138. J.M.Tirado-Velez, I.Joumady, A.Saez-Benito, et al. (2012). Inhibition of fatty acid metabolism reduces human myeloma cells proliferation. PLoS One 7:e46484.
139. N.K.Tonks (2005). Redox redux:revisiting PTPs and the control of cell signaling. Cell 121:667–70.
140. Z.Tothova, R.Kollipara, B.J.Huntly, et al. (2007). FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128:325–39.
141. D.A.Tuveson, R.H.Carter, S.P.Soltoff, D.T.Fearon (1993). CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260:986–9.
142. G.J.Van Der Windt, B.Everts, C.H.Chang, et al. (2012). Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36:68–78.
143. J.Velez, N.HailJr., M.Konopleva, et al. (2013). Mitochondrial uncoupling and the reprograming of intermediary metabolism in leukemia cells. Front Oncol 3:67.
144. R.Vene, L.Delfino, P.Castellani, et al. (2010). Redox remodeling allows and controls B-cell activation and differentiation. Antioxid Redox Signal 13:1145–55.
145. R.K.Venigalla, V.A.McGuire, R.Clarke, et al. (2013). PDK1 regulates VDJ recombination, cell-cycle exit and survival during B-cell development. Embo J 32:1008–22.
146. G.D.Victora, T.A.Schwickert, D.R.Fooksman, et al. (2010). Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143:592–605.
147. D.C.Wallace, W.Fan, V.Procaccio (2010). Mitochondrial energetics and therapeutics. Annu Rev Pathol 5:297–348.
148. R.C.Wang, Y.Wei, Z.An, et al. (2012). Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science 338:956–9.
149. M.Watanabe-Matsui, A.Muto, T.Matsui, et al. (2011). Heme regulates B-cell differentiation, antibody class switch, and heme oxygenase-1 expression in B cells as a ligand of Bach2. Blood 117:5438–48.
150. M.Werner, E.Hobeika, H.Jumaa (2010). Role of PI3K in the generation and survival of B cells. Immunol Rev 237:55–71.
151. M.L.Wheeler, A.L.Defranco (2012). Prolonged production of reactive oxygen species in response to B cell receptor stimulation promotes B cell activation and proliferation. J Immunol 189:4405–16.
152. L.S.Wicker, R.C.BoltzJr, V.Matt, et al. (1990). Suppression of B cell activation by cyclosporin A, FK506 and rapamycin. Eur J Immunol 20:2277–83.
153. R.T.Woodland, C.J.Fox, M.R.Schmidt, et al. (2008). Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 111:750–60.
154. H.X.Yuan, Y.Xiong, K.L.Guan (2013). Nutrient sensing, metabolism, and cell growth control. Mol Cell 49:379–87.
155. H.Zha, M.Raffeld, L.Charboneau, et al. (2004). Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab Invest 84:235–44.
156. Y.Zhang, T.Hu, C.Hua, et al. (2014). Rictor is required for early B cell development in bone marrow. PLoS One 9:e103970.
157. S.Zhang, M.Pruitt, D.Tran, et al. (2013). B cell-specific deficiencies in mTOR limit humoral immune responses. J Immunol 191:1692–703.
158. S.Zhang, J.A.Readinger, W.Dubois, et al. (2011). Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. Blood 117:1228–38.
159. Y.Zhao, B.J.Altman, J.L.Coloff, et al. (2007). Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1. Mol Cell Biol 27:4328–39.